Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Mar 22, 2023, after the close
10-K filed Mar 22, 2023, 81 days after period end · 0000950170-23-009226
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | $2.50K | $2.50K |
| Net Income | -$3.72M | $1.07M | -$4.24M |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$2.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
